Chronic Fragmentation of the Daily Sleep-Wake Rhythm Increases Amyloid-beta Levels and Neuroinflammation in the 3xTg-AD Mouse Model of Alzheimer's Disease. 2022

M J Duncan, and L E Guerriero, and K Kohler, and L E Beechem, and B D Gillis, and F Salisbury, and C Wessel, and J Wang, and S Sunderam, and A D Bachstetter, and B F O'Hara, and M P Murphy
Dept. of Neuroscience, University of Kentucky College of Medicine, Lexington, KY 40536, United States. Electronic address: mjdunc0@uky.edu.

Fragmentation of the daily sleep-wake rhythm with increased nighttime awakenings and more daytime naps is correlated with the risk of development of Alzheimer's disease (AD). To explore whether a causal relationship underlies this correlation, the present study tested the hypothesis that chronic fragmentation of the daily sleep-wake rhythm stimulates brain amyloid-beta (Aβ) levels and neuroinflammation in the 3xTg-AD mouse model of AD. Female 3xTg-AD mice were allowed to sleep undisturbed or were subjected to chronic sleep fragmentation consisting of four daily sessions of enforced wakefulness (one hour each) evenly distributed during the light phase, five days a week for four weeks. Piezoelectric sleep recording revealed that sleep fragmentation altered the daily sleep-wake rhythm to resemble the pattern observed in AD. Levels of amyloid-beta (Aβ40 and Aβ42) determined by ELISA were higher in hippocampal tissue collected from sleep-fragmented mice than from undisturbed controls. In contrast, hippocampal levels of tau and phospho-tau differed minimally between sleep fragmented and undisturbed control mice. Sleep fragmentation also stimulated neuroinflammation as shown by increased expression of markers of microglial activation and proinflammatory cytokines measured by q-RT-PCR analysis of hippocampal samples. No significant effects of sleep fragmentation on Aβ, tau, or neuroinflammation were observed in the cerebral cortex. These studies support the concept that improving sleep consolidation in individuals at risk for AD may be beneficial for slowing the onset or progression of this devastating neurodegenerative disease.

UI MeSH Term Description Entries
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000090862 Neuroinflammatory Diseases Diseases characterized by inflammation of the nervous tissue. Neuroinflammation,Neuroinflammatory Disorders,Disease, Neuroinflammatory,Disorder, Neuroinflammatory,Neuroinflammations,Neuroinflammatory Disease,Neuroinflammatory Disorder
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012890 Sleep A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility. Sleep Habits,Sleeping Habit,Sleeping Habits,Habit, Sleep,Habit, Sleeping,Habits, Sleep,Habits, Sleeping,Sleep Habit
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid
D016564 Amyloid beta-Protein Precursor A single-pass type I membrane protein. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid peptide, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES. Amyloid A4 Protein Precursor,Amyloid Protein Precursor,beta-Amyloid Protein Precursor,Amyloid beta Precursor Protein,Protease Nexin 2,Protease Nexin II,Amyloid beta Protein Precursor,Nexin 2, Protease,Nexin II, Protease,beta Amyloid Protein Precursor,beta-Protein Precursor, Amyloid
D016875 tau Proteins Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES). tau Protein,Protein, tau,Proteins, tau

Related Publications

M J Duncan, and L E Guerriero, and K Kohler, and L E Beechem, and B D Gillis, and F Salisbury, and C Wessel, and J Wang, and S Sunderam, and A D Bachstetter, and B F O'Hara, and M P Murphy
April 2015, Neuroscience,
M J Duncan, and L E Guerriero, and K Kohler, and L E Beechem, and B D Gillis, and F Salisbury, and C Wessel, and J Wang, and S Sunderam, and A D Bachstetter, and B F O'Hara, and M P Murphy
February 2019, Scientific reports,
M J Duncan, and L E Guerriero, and K Kohler, and L E Beechem, and B D Gillis, and F Salisbury, and C Wessel, and J Wang, and S Sunderam, and A D Bachstetter, and B F O'Hara, and M P Murphy
November 2022, Genes, brain, and behavior,
M J Duncan, and L E Guerriero, and K Kohler, and L E Beechem, and B D Gillis, and F Salisbury, and C Wessel, and J Wang, and S Sunderam, and A D Bachstetter, and B F O'Hara, and M P Murphy
January 2021, Frontiers in neuroscience,
M J Duncan, and L E Guerriero, and K Kohler, and L E Beechem, and B D Gillis, and F Salisbury, and C Wessel, and J Wang, and S Sunderam, and A D Bachstetter, and B F O'Hara, and M P Murphy
September 2010, Neurobiology of aging,
M J Duncan, and L E Guerriero, and K Kohler, and L E Beechem, and B D Gillis, and F Salisbury, and C Wessel, and J Wang, and S Sunderam, and A D Bachstetter, and B F O'Hara, and M P Murphy
August 2022, Biomedicines,
M J Duncan, and L E Guerriero, and K Kohler, and L E Beechem, and B D Gillis, and F Salisbury, and C Wessel, and J Wang, and S Sunderam, and A D Bachstetter, and B F O'Hara, and M P Murphy
May 2023, Nutrients,
M J Duncan, and L E Guerriero, and K Kohler, and L E Beechem, and B D Gillis, and F Salisbury, and C Wessel, and J Wang, and S Sunderam, and A D Bachstetter, and B F O'Hara, and M P Murphy
January 2018, Journal of Alzheimer's disease : JAD,
M J Duncan, and L E Guerriero, and K Kohler, and L E Beechem, and B D Gillis, and F Salisbury, and C Wessel, and J Wang, and S Sunderam, and A D Bachstetter, and B F O'Hara, and M P Murphy
July 2017, Neuroscience letters,
M J Duncan, and L E Guerriero, and K Kohler, and L E Beechem, and B D Gillis, and F Salisbury, and C Wessel, and J Wang, and S Sunderam, and A D Bachstetter, and B F O'Hara, and M P Murphy
July 2022, Journal of neuroinflammation,
Copied contents to your clipboard!